View in EDS PDF Full Text

Periostin expression in uninvolved skin as a potential biomarker for rapid cutaneous progression in systemic sclerosis patients: a preliminary explorative study.

Saved in:
Bibliographic Details
Title: Periostin expression in uninvolved skin as a potential biomarker for rapid cutaneous progression in systemic sclerosis patients: a preliminary explorative study.
Authors: De Luca G; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milan, Italy.; School of Medicine, Vita-Salute San Raffaele University, Milan, Italy., Campochiaro C; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milan, Italy.; School of Medicine, Vita-Salute San Raffaele University, Milan, Italy., Burastero SE; Unit of Cellular and Molecular Allergology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Matucci-Cerinic M; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milan, Italy.; Division of Rheumatology AOUC, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Doglioni C; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milan, Italy.; Unit of Cellular and Molecular Allergology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Dagna L; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milan, Italy.; School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Source: Frontiers in medicine [Front Med (Lausanne)] 2024 Jan 24; Vol. 10, pp. 1214523. Date of Electronic Publication: 2024 Jan 24 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2296-858X
DOI:10.3389/fmed.2023.1214523